{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:21:12Z","timestamp":1789503672547,"version":"build-2803163510"},"reference-count":228,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189702","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:15:41Z","timestamp":1788948941000},"page":"189702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response"],"prefix":"10.1016","volume":"1881","author":[{"given":"Jinghao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Yue","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189702_bb0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189702_bb0025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps - myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci. (Lond., Engl.: 1979)"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2022.12.003","article-title":"Control of tumor-associated macrophage responses by nutrient acquisition and metabolism","volume":"56","author":"Zhang","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1073\/pnas.1614035114","article-title":"Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0060","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910698","article-title":"Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages","volume":"11","author":"Wu","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189702_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2021.03.005","article-title":"Tryptophan metabolism in brain tumors - IDO and beyond","volume":"70","author":"Platten","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","article-title":"Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase","volume":"11","author":"Palmieri","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0075","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"issue":"7779","key":"10.1016\/j.bbcan.2026.189702_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","article-title":"The intersection of epigenetics and metabolism in trained immunity","volume":"54","author":"Fanucchi","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189702_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of tumor-associated macrophages: a therapeutic perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/pro6.70012","article-title":"Radiotherapy after neoadjuvant Immunochemotherapy in Unresectable stage III non-small cell lung carcinoma: a novel therapeutic approach?","volume":"9","author":"Wu","year":"2025","journal-title":"Precis. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/pro6.70043","article-title":"Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive-stage small-cell lung cancer: a retrospective analysis of survival outcomes","volume":"9","author":"Han","year":"2025","journal-title":"Precis. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0115","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fimmu.2020.01276","article-title":"Antigen cross-presentation by macrophages","volume":"11","author":"Muntjewerff","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mc.23354","article-title":"Amateur antigen-presenting cells in the tumor microenvironment","volume":"61","author":"Darragh","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0125","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-24-2982","article-title":"Macrophage-derived Itaconate suppresses dendritic cell function to promote acquired resistance to anti-PD-1 immunotherapy","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0130","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI97642","article-title":"Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance","volume":"129","author":"Muraoka","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","article-title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","volume":"41","author":"Kilian","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189702_bb0145","doi-asserted-by":"crossref","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0150","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006401","article-title":"Barriers to immune cell infiltration in tumors","volume":"11","author":"Melssen","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0165","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0170","first-page":"1045","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189702_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.874589","article-title":"Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression","volume":"13","author":"Pu","year":"2022","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.bbcan.2026.189702_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm8660","article-title":"Targeting conserved TIM3(+)VISTA(+) tumor-associated macrophages overcomes resistance to cancer immunotherapy","volume":"10","author":"Vanmeerbeek","year":"2024","journal-title":"Sci. Adv."},{"issue":"48","key":"10.1016\/j.bbcan.2026.189702_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq8122","article-title":"Identification of VISTA regulators in macrophages mediating cancer cell survival","volume":"10","author":"Abdrabou","year":"2024","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0190","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189702_bb0200","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2217\/fon-2023-0871","article-title":"Regulatory role of CD39 and CD73 in tumor immunity","volume":"20","author":"Kaplinsky","year":"2024","journal-title":"Fut. Oncol. (Lond., Engl.)"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0205","first-page":"995","article-title":"Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy","volume":"21","author":"Yang","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0210","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","article-title":"Prostaglandin E(2)-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells","volume":"15","author":"Punyawatthananukool","year":"2024","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189702_bb0215","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1158\/0008-5472.CAN-16-1114","article-title":"Tie2 expression on macrophages is required for blood vessel reconstruction and tumor relapse after chemotherapy","volume":"76","author":"Chen","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0220","first-page":"2301","article-title":"Hypoxia-inducible factor \u03b1 subunits regulate Tie2-expressing macrophages that influence tumor oxygen and perfusion in murine breast Cancer","volume":"205","author":"Steinberger","year":"2020","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/0008-5472.CAN-18-2545","article-title":"Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis","volume":"79","author":"Jeong","year":"2019","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41416-019-0542-2","article-title":"Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer","volume":"121","author":"El-Kenawi","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1172\/JCI123027","article-title":"Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2\u03b1-mediated tumor progression","volume":"129","author":"Liu","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0240","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0245","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1700600114","article-title":"Metabolic origins of spatial organization in the tumor microenvironment","volume":"114","author":"Carmona-Fontaine","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0250","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2023.05.036","article-title":"Spatially resolved multi-omics single-cell analyses inform mechanisms of immune dysfunction in pancreatic cancer","volume":"165","author":"Yousuf","year":"2023","journal-title":"Gastroenterology"},{"issue":"44","key":"10.1016\/j.bbcan.2026.189702_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2419568122","article-title":"Metabolic adaptation of glucose-deprived macrophages involves partial gluconeogenesis","volume":"122","author":"Schindlmaier","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0260","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","volume":"11","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0265","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0270","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210564","article-title":"Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer","volume":"219","author":"Masetti","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189702_bb0275","article-title":"Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis","volume":"12","author":"Saab","year":"2023","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0280","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0290","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0295","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI84431","article-title":"HIF1\u03b1 and metabolic reprogramming in inflammation","volume":"126","author":"Corcoran","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189702_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade5111","article-title":"Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development","volume":"9","author":"Cheu","year":"2023","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.03.021","article-title":"25-hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages","volume":"57","author":"Xiao","year":"2024","journal-title":"Immunity"},{"issue":"7629","key":"10.1016\/j.bbcan.2026.189702_bb0310","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3K\u03b3 is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"issue":"42","key":"10.1016\/j.bbcan.2026.189702_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax8189","article-title":"GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment","volume":"4","author":"Halaby","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.961753","article-title":"The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: enhanced tumor inflammation and metastasis","volume":"12","author":"Delprat","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0325","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41590-022-01185-3","article-title":"Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation","volume":"23","author":"Billingham","year":"2022","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri2975","article-title":"Mitochondria in innate immune responses","volume":"11","author":"West","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s11658-024-00575-9","article-title":"Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7\/IRF3 activation to aggravate lung injury during severe acute pancreatitis","volume":"29","author":"Peng","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbcan.2026.189702_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1082213","article-title":"The mitochondrial Ca2+ channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation","volume":"11","author":"Fernandez Garcia","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110110","article-title":"PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma","volume":"759","author":"Ghosh","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"51","key":"10.1016\/j.bbcan.2026.189702_bb0350","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1074\/jbc.RA118.003935","article-title":"Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-\u03baB signaling","volume":"293","author":"De","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109384","article-title":"NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death","volume":"27","author":"Debsharma","year":"2024","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0360","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s42255-025-01224-x","article-title":"Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1\u03b2 release during NLRP3 inflammasome activation","volume":"7","author":"Casey","year":"2025","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0365","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1073\/pnas.1819473116","article-title":"Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1","volume":"116","author":"Roux","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq7307","article-title":"Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion","volume":"11","author":"Zotta","year":"2025","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0375","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","article-title":"Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate Lyase","volume":"51","author":"Lauterbach","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0380","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41590-022-01145-x","article-title":"PERK is a critical metabolic hub for immunosuppressive function in macrophages","volume":"23","author":"Raines","year":"2022","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0385","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jhep.2024.05.007","article-title":"Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8(+) T cells in hepatocellular carcinoma","volume":"81","author":"Zhu","year":"2024","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0390","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate Immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189702_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.132932","article-title":"Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease","volume":"464","author":"Noh","year":"2024","journal-title":"J. Hazard. Mater."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.06.039","article-title":"One-carbon metabolism supports S-Adenosylmethionine and histone methylation to drive inflammatory macrophages","volume":"75","author":"Yu","year":"2019","journal-title":"Mol. Cell"},{"issue":"38","key":"10.1016\/j.bbcan.2026.189702_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq5226","article-title":"NF-\u03baB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment","volume":"10","author":"de la Calle-Fabregat","year":"2024","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0410","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","article-title":"Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses","volume":"24","author":"Chen","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189702_bb0415","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189702_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608115","article-title":"The lactylation-macrophage interplay: implications for gastrointestinal disease therapeutics","volume":"16","author":"Che","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0425","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2017.10.037","article-title":"Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship","volume":"413","author":"Netea-Maier","year":"2018","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189702_bb0430","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/CM9.0000000000002426","article-title":"Metabolic reprogramming in the immunosuppression of tumor-associated macrophages","volume":"135","author":"Wang","year":"2022","journal-title":"Chin. Med. J."},{"issue":"7519","key":"10.1016\/j.bbcan.2026.189702_bb0435","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0440","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmet.2016.09.008","article-title":"Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis","volume":"24","author":"Wenes","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189702_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1208870","article-title":"Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy","volume":"14","author":"Tao","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189702_bb0450","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1136\/gutjnl-2021-326350","article-title":"PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma","volume":"71","author":"Lu","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0455","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2019.04.007","article-title":"Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma","volume":"71","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0460","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.7150\/ijbs.91492","article-title":"Histone lactylation: from tumor lactate metabolism to epigenetic regulation","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189702_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110171","article-title":"Macrophages are metabolically heterogeneous within the tumor microenvironment","volume":"37","author":"Geeraerts","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113746","article-title":"Lactic acid induces transcriptional repression of macrophage inflammatory response via histone acetylation","volume":"43","author":"Shi","year":"2024","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0475","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0480","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor Immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70372","article-title":"Polarization of tumor cells and tumor-associated macrophages: molecular mechanisms and therapeutic targets","volume":"6","author":"Wei","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bbcan.2026.189702_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115369","article-title":"Immunometabolic attributes and mitochondria-associated signaling of tumor-associated macrophages in tumor microenvironment modulate cancer progression","volume":"208","author":"Dubey","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189471","article-title":"Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression","volume":"1880","author":"Ghosh","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189702_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150268","article-title":"Immunometabolic characteristics of dendritic cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression","volume":"726","author":"Ghosh","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0505","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13578-024-01201-z","article-title":"Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment","volume":"14","author":"Cao","year":"2024","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0510","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.smim.2015.09.001","article-title":"Contribution of metabolic reprogramming to macrophage plasticity and function","volume":"27","author":"El Kasmi","year":"2015","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0520","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0525","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8(+) T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010217","article-title":"Inhibition of PFKFB3 in macrophages has a dual effect on tumor-regulating lipid metabolism","volume":"27","author":"Shmakova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189702_bb0535","series-title":"Breaking Glycolysis Barriers to Immunotherapy with Nanomedicines","author":"Zhang","year":"2025"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189702_bb0540","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177606","article-title":"Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models","volume":"134","author":"Verma","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189702_bb0545","article-title":"Lipid metabolic reprogramming in the tumor microenvironment and its mechanistic role in immunosuppressive cells","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0550","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0555","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/0008-5472.CAN-23-4027","article-title":"Scavenger receptor CD36 in tumor-associated macrophages promotes Cancer progression by dampening type-I IFN signaling","volume":"85","author":"Xu","year":"2025","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189702_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146838","article-title":"Macrophages at the crossroads of chronic stress and Cancer","volume":"26","author":"Mom\u010dilovi\u0107","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0565","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx5490","article-title":"Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells","volume":"12","author":"Bendre","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189702_bb0570","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101221","article-title":"FABP4-mediated lipid accumulation and lipolysis in tumor-associated macrophages promote breast cancer metastasis","volume":"13","author":"Yorek","year":"2024","journal-title":"eLife"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189702_bb0575","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1097\/CM9.0000000000003916","article-title":"Lipid droplets in the tumor microenvironment: biogenesis, functional diversity, and therapeutic targeting","volume":"138","author":"Zhong","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbcan.2026.189702_bb0580","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2017.00609","article-title":"Fatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes","volume":"8","author":"Raulien","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0585","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221472","article-title":"Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages","volume":"220","author":"Gonzalez","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189702_bb0590","article-title":"Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0595","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0600","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1111\/cas.14616","article-title":"Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer","volume":"111","author":"Luo","year":"2020","journal-title":"Cancer Sci."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189702_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512032","article-title":"Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity","volume":"24","author":"Vassiliou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13072-025-00575-9","article-title":"Crosstalk between metabolism and epigenetics during macrophage polarization","volume":"18","author":"Zhang","year":"2025","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061411","article-title":"Transcriptional, epigenetic and metabolic programming of tumor-associated macrophages","volume":"12","author":"Larionova","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189702_bb0620","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.ircmb.2022.01.004","article-title":"Metabolism in tumor-associated macrophages","volume":"367","author":"Li","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70090","article-title":"The phenotypical and functional effect of PGE2 on human macrophages","volume":"55","author":"Pfirrmann","year":"2025","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0630","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-associated macrophages produce PGE2 to promote CD8+ T-cell exhaustion and drive resistance to PD-L1 blockade in microsatellite-stable colorectal cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189702_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/biology9120434","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti","year":"2020","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0640","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41423-024-01199-x","article-title":"Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma","volume":"21","author":"Wang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0645","first-page":"726","article-title":"Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies","volume":"22","author":"Lin","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0650","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0655","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for Cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0660","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12672-025-02238-3","article-title":"Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications","volume":"16","author":"Shende","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0665","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009930","article-title":"Arginase-1-specific T cells target and modulate tumor-associated macrophages","volume":"13","author":"Martinenaite","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc8929","article-title":"Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma","volume":"7","author":"Miska","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189702_bb0675","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in Cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0680","article-title":"First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours","volume":"3","author":"Naing","year":"2024","journal-title":"BMJ Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0685","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"Pt A","key":"10.1016\/j.bbcan.2026.189702_bb0690","article-title":"Indoleamine 2,3-dioxygenase-1 involves in CD8(+)T cell exhaustion in glioblastoma via regulating tryptophan levels","volume":"142","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0695","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0700","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00262-025-04065-5","article-title":"Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies","volume":"74","author":"De Castro","year":"2025","journal-title":"Cancer Immunol. Immunother.: CII"},{"key":"10.1016\/j.bbcan.2026.189702_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1461455","article-title":"Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0710","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80721","article-title":"Arginase 1 is a key driver of immune suppression in pancreatic cancer","volume":"12","author":"Menjivar","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.bbcan.2026.189702_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217972","article-title":"The epigenetic landscape of tumor-associated macrophages: orchestrating immune evasion in the tumor microenvironment","volume":"632","author":"Liu","year":"2025","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189702_bb0720","article-title":"Lactylation-Driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma","volume":"12","author":"Cai","year":"2025","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0725","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0730","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14728222.2016.1139085","article-title":"Epigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 polyunsaturated fatty acid targets in colon inflammation and cancer","volume":"20","author":"Serini","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"48","key":"10.1016\/j.bbcan.2026.189702_bb0735","doi-asserted-by":"crossref","first-page":"30628","DOI":"10.1073\/pnas.2009778117","article-title":"TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation","volume":"117","author":"Irizarry-Caro","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0740","article-title":"PERK promotes immunosuppressive M2 macrophage phenotype by metabolic reprogramming and epigenetic modifications through the PERK-ATF4-PSAT1 axis","volume":"4","author":"Pratap","year":"2022","journal-title":"Immunometabolism (Cobham, Surrey)"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0745","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0750","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbcan.2026.189702_bb0755","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fimmu.2019.02019","article-title":"Function of CSF1 and IL34 in macrophage homeostasis, inflammation, and cancer","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0760","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189702_bb0765","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155022","article-title":"CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity","volume":"7","author":"Modak","year":"2022","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0775","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0780","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0785","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189702_bb0790","series-title":"Coenzyme a Governs Proinflammatory Macrophage Metabolism","author":"Timblin","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189702_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636081","article-title":"Tryptophan: a rheostat of cancer immune escape mediated by immunosuppressive enzymes IDO1 and TDO","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"issue":"7629","key":"10.1016\/j.bbcan.2026.189702_bb0800","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189702_bb0805","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-22-3313","article-title":"Eganelisib, a first-in-class PI3K\u03b3 inhibitor, in patients with advanced solid tumors: results of the phase 1\/1b MARIO-1 trial","volume":"29","author":"Hong","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0810","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0815","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2326-6066.CIR-19-0041","article-title":"Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors","volume":"8","author":"Schramme","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110316","article-title":"The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA","volume":"301","author":"Lara","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"7645","key":"10.1016\/j.bbcan.2026.189702_bb0825","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature21409","article-title":"Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages","volume":"543","author":"Guerriero","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb0830","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41580-018-0029-7","article-title":"Regulation of chromatin and gene expression by metabolic enzymes and metabolites","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb0835","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41388-020-01636-x","article-title":"HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0840","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1515\/jtim-2025-0020","article-title":"Nano particle loaded EZH2 inhibitors: increased efficiency and reduced toxicity for malignant solid tumors","volume":"13","author":"Guo","year":"2025","journal-title":"J. Transl. Intern. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0845","article-title":"Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment","volume":"12","author":"O\u2019Connell","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0850","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011284","article-title":"Phase 1b\/2 study of BMS-813160, a CCR2\/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer","volume":"14","author":"Le","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0855","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10637-019-00830-3","article-title":"Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel\/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma","volume":"38","author":"Noel","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0860","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0865","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1113873109","article-title":"Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase","volume":"109","author":"Pilotte","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"389","key":"10.1016\/j.bbcan.2026.189702_bb0870","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3604","article-title":"In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189702_bb0880","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16825","article-title":"Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment","volume":"12","author":"Cheng","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.bbcan.2026.189702_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1496390","article-title":"Lactate: a rising star in tumors and inflammation","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189702_bb0890","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0895","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0900","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1515\/jtim-2025-0047","article-title":"Protocol for Chinese lung cancer evolution and microenvironment tracking under therapy study","volume":"13","author":"Wang","year":"2025","journal-title":"J. Transl. Intern. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110609","article-title":"Metabolism drives macrophage heterogeneity in the tumor microenvironment","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb0910","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tips.2024.02.005","article-title":"Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls","volume":"45","author":"Saha","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2026.189702_bb0915","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69578","article-title":"Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues","volume":"10","author":"Fan","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0920","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41698-024-00660-4","article-title":"Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census","volume":"8","author":"Wei","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189702_bb0925","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1515\/jtim-2025-0052","article-title":"A signature of plasma exosomal miRNAs predict therapeutic efficacy to neoadjuvant immunotherapy in patients with non-small cell lung cancer","volume":"13","author":"Zhai","year":"2025","journal-title":"J. Transl. Intern. Med."},{"issue":"31","key":"10.1016\/j.bbcan.2026.189702_bb0930","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505789122","article-title":"Integrating spatial omics and single-cell mass spectrometry imaging reveals tumor-host metabolic interplay in hepatocellular carcinoma","volume":"122","author":"Chen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0935","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.03.021","article-title":"ZEB2 is a master switch controlling the tumor-associated macrophage program","volume":"43","author":"Sheban","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0945","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2024.03.016","article-title":"FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma","volume":"81","author":"Xu","year":"2024","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0950","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cas.16073","article-title":"Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8(+) T cell infiltration in melanoma","volume":"115","author":"Hirose","year":"2024","journal-title":"Cancer Sci."},{"issue":"42","key":"10.1016\/j.bbcan.2026.189702_bb0955","doi-asserted-by":"crossref","first-page":"28764","DOI":"10.1021\/acsnano.4c07903","article-title":"Harnessing the power of sugar-based nanoparticles: a drug-free approach to enhance immune checkpoint inhibition against glioblastoma and pancreatic Cancer","volume":"18","author":"Hsu","year":"2024","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189702_bb0960","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.7150\/ijbs.117909","article-title":"DPP7 promotes fatty acid \u03b2-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer","volume":"21","author":"Chang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb0965","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.apsb.2021.05.016","article-title":"Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189702_bb0970","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187024","article-title":"Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma","volume":"135","author":"Sun","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb0975","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2767-9764.CRC-23-0513","article-title":"Targeting tryptophan catabolism in ovarian Cancer to attenuate macrophage infiltration and PD-L1 expression","volume":"4","author":"Crump","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189702_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.703465","article-title":"A novel Oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment","volume":"11","author":"Pilanc","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0985","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70223","article-title":"A phosphatidylinositol 3-kinase gamma inhibitor enhances anti-programmed Death-1\/programmed death Ligand-1 antitumor effects by remodeling the tumor immune microenvironment of ovarian cancer","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb0990","first-page":"1206","article-title":"Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance","volume":"5","author":"Scolaro","year":"2024","journal-title":"Nat. Can."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189702_bb0995","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41556-025-01839-y","article-title":"Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma","volume":"28","author":"Li","year":"2026","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb1000","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70340","article-title":"VSIG4 promotes tumour-associated macrophage M2 polarization and immune escape in colorectal Cancer via fatty acid oxidation pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189702_bb1005","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/0008-5472.CAN-25-1693","article-title":"Long-chain fatty acid redistribution induced by slc27a2 deficiency facilitates hypoxic adaptation and immunosuppression in hepatocellular carcinoma","volume":"85","author":"Fu","year":"2025","journal-title":"Cancer Res."},{"issue":"30","key":"10.1016\/j.bbcan.2026.189702_bb1010","first-page":"19875","article-title":"Carrier-free photodynamic bioregulators inhibiting lactic acid efflux combined with immune checkpoint blockade for triple-negative breast cancer immunotherapy","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189702_bb1015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41423-024-01134-0","article-title":"Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling","volume":"21","author":"Cai","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1020","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1025","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","article-title":"Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice","volume":"16","author":"Wen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189702_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101272","article-title":"Metabolic reprogramming of tumor-associated macrophages via adenosine-A(2A)R signaling drives cross-resistance in non-small cell lung cancer","volume":"82","author":"Ding","year":"2025","journal-title":"Drug Res. Updates: Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12951-025-03629-y","article-title":"Genetically engineered magnesium\/manganese nanoparticles for cancer radioimmunotherapy","volume":"23","author":"Wu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189702_bb1040","first-page":"e13606","article-title":"IL4I1+ macrophages and TDO2+ myofibroblasts drive AhR-mediated immunosuppression and ferroptosis resistance in solid predominant lung adenocarcinoma","volume":"13","author":"Wang","year":"2026","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.bbcan.2026.189702_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12951-025-03507-7","article-title":"Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41419-025-08402-5","article-title":"PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma","volume":"17","author":"Szyd\u0142owski","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12935-025-04113-1","article-title":"Metabolic-transcriptional rewiring by NFE2L2 promotes M2 macrophage polarization and anti-PD-L1 resistance in glioma","volume":"26","author":"Tian","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014043","article-title":"Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity","volume":"14","author":"Liu","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"47","key":"10.1016\/j.bbcan.2026.189702_bb1070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302126120","article-title":"NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages","volume":"120","author":"Yuan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189702_bb1075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00262-023-03603-3","volume":"73","author":"Li","year":"2024","journal-title":"Cancer Immunol. Immunother.: CII"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-025-02559-3","article-title":"Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer","volume":"11","author":"Singh","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1085","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat. Commun."},{"issue":"8048","key":"10.1016\/j.bbcan.2026.189702_bb1090","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb1095","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/cas.70130","article-title":"ONO-4578 plus nivolumab in unresectable advanced or recurrent gastric or gastroesophageal junction cancer","volume":"116","author":"Kawazoe","year":"2025","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-018-1537-8","article-title":"Pharmacological characterisation of CR6086, a potent prostaglandin E(2) receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug","volume":"20","author":"Caselli","year":"2018","journal-title":"Arthritis Res. Therapy"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189702_bb1105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1078-0432.CCR-24-2611","article-title":"The prostaglandin EP4 antagonist vorbipiprant combined with pd-1 blockade for refractory microsatellite-stable metastatic colorectal cancer: a phase Ib\/IIa Trial","volume":"31","author":"Pietrantonio","year":"2025","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189702_bb1110","doi-asserted-by":"crossref","first-page":"S529","DOI":"10.1016\/j.annonc.2024.08.745","article-title":"679TiP cancer research UK phase I\/IIa trial of the prostaglandin E2 (PGE2) receptor 4 (EP4) antagonist HTL0039732 as monotherapy and in combination with immunotherapy in patients (pts) with advanced solid tumors","volume":"35","author":"Sarker","year":"2024","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189702_bb1115","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70009","article-title":"The co-location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non-small cell lung cancer","volume":"14","author":"Fan","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189702_bb1120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12967-025-06692-z","article-title":"Knocking down hypoxia-induced Semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization","volume":"23","author":"Yi","year":"2025","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189702_bb1125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006457","article-title":"Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma","volume":"11","author":"Graziano","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189702_bb1130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012314","article-title":"Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8(+) T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma","volume":"13","author":"Jia","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"33","key":"10.1016\/j.bbcan.2026.189702_bb1135","article-title":"Identification of Hypoxia-ALCAM(high) macrophage- exhausted T cell axis in tumor microenvironment remodeling for immunotherapy resistance","volume":"11","author":"Xun","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.bbcan.2026.189702_bb1140","article-title":"Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:57:10Z","timestamp":1789502230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":228,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001745"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189702","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189702"}}